Nantahala Capital Management, LLC 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

Nantahala Capital Management, LLC 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
4:53 pm
Purchase
2024-09-30 13G Aprea Therapeutics, Inc.
APRE
Nantahala Capital Management, LLC 411,520
7.300%
411,520increase
(New Position)
Filing